News | April 27, 2026
Nihilent unveils nSEPIA Beta to turn emotional wellness into measurable science
nSEPIA aims to bring structure to an area long dominated by subjectivity
nSEPIA aims to bring structure to an area long dominated by subjectivity
_256_384.jpg)
The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA
FTIR and machine learning-based technology enables real-time, cost-effective quantification of food adulterants
New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care
AI-powered platform uses real-time emotion scanning and personalised interventions to make emotional wellness measurable and actionable
Multi-stakeholder initiative highlights inclusive sports pathways, honours neurodivergent athletes, and calls for systemic reforms
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network
New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
Subscribe To Our Newsletter & Stay Updated
